Literature DB >> 20501516

Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect.

María F Henning1, Vanesa Herlax, Laura Bakás.   

Abstract

It is well known that high density lipoprotein (HDL) binds bacterial lipopolysaccharide (LPS) and neutralizes its toxicity. The aim of this work was to study changes in the apolipoprotein (apo) AI structure after its interaction with LPS as well as to determine the protein domain involved in that interaction. The presented data indicate that LPS does not lead to major changes in the structure of apoAI, judging from Trp fluorescence spectra. However, analysis of denaturation behavior and binding of ANS show that LPS induces a loosened protein conformation. Further evidence for an apoAI-LPS specific interaction was obtained by incubation of the protein with (125)I-ASD-LPS. The results show that multiple regions of the protein were able to interact with LPS, according to its amphiphatic nature. Finally, the contribution of the purified C-terminal fragment of the protein in the endotoxin neutralization was evaluated in comparison with the effect of apoAI. In both cases, the same decrease in tumor necrosis factor-α released was observed. This result suggests that the C-terminal half of apoAI is the main domain responsible of the neutralization effect of this protein. Our data may provide innovative pharmacological tools in endotoxin neutralization therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501516     DOI: 10.1177/1753425910370709

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  15 in total

1.  Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3.

Authors:  Marta Biedzka-Sarek; Jari Metso; Andreas Kateifides; Taru Meri; T Sakari Jokiranta; Artur Muszyński; Joanna Radziejewska-Lebrecht; Vassilis Zannis; Mikael Skurnik; Matti Jauhiainen
Journal:  J Biol Chem       Date:  2011-09-06       Impact factor: 5.157

2.  Expression of the C-terminal domain of human apolipoprotein A-I using a chimeric apolipoprotein.

Authors:  Daniel E Sallee; James V C Horn; Lukas A Fuentes; Paul M M Weers
Journal:  Protein Expr Purif       Date:  2017-06-15       Impact factor: 1.650

Review 3.  The A's Have It: Developing Apolipoprotein A-I Mimetic Peptides Into a Novel Treatment for Asthma.

Authors:  Xianglan Yao; Elizabeth M Gordon; Amisha V Barochia; Alan T Remaley; Stewart J Levine
Journal:  Chest       Date:  2016-06-18       Impact factor: 9.410

Review 4.  High-density lipoprotein: a novel target for antirestenosis therapy.

Authors:  Kai Yin; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2014-07-15       Impact factor: 4.689

5.  Endotoxin contamination of apolipoprotein A-I: effect on macrophage proliferation--a cautionary tale.

Authors:  Xueting Jin; Qing Xu; Keith Champion; Howard S Kruth
Journal:  Atherosclerosis       Date:  2015-03-09       Impact factor: 5.162

6.  Transfer of C-terminal residues of human apolipoprotein A-I to insect apolipophorin III creates a two-domain chimeric protein with enhanced lipid binding activity.

Authors:  James V C Horn; Rachel A Ellena; Jesse J Tran; Wendy H J Beck; Vasanthy Narayanaswami; Paul M M Weers
Journal:  Biochim Biophys Acta Biomembr       Date:  2017-04-21       Impact factor: 3.747

7.  Apolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: role for lysine residues in antimicrobial properties.

Authors:  Wendy H J Beck; Christopher P Adams; Ivan M Biglang-Awa; Arti B Patel; Heather Vincent; Eric J Haas-Stapleton; Paul M M Weers
Journal:  Biochim Biophys Acta       Date:  2013-02-26

Review 8.  Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.

Authors:  Xianglan Yao; Elizabeth M Gordon; Debbie M Figueroa; Amisha V Barochia; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

Review 9.  High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease.

Authors:  Elizabeth M Gordon; Debbie M Figueroa; Amisha V Barochia; Xianglan Yao; Stewart J Levine
Journal:  Front Pharmacol       Date:  2016-09-21       Impact factor: 5.810

10.  Sub-emetic toxicity of Bacillus cereus toxin cereulide on cultured human enterocyte-like Caco-2 cells.

Authors:  Andreja Rajkovic; Charlotte Grootaert; Ana Butorac; Tatiana Cucu; Bruno De Meulenaer; John van Camp; Marc Bracke; Mieke Uyttendaele; Višnja Bačun-Družina; Mario Cindrić
Journal:  Toxins (Basel)       Date:  2014-08-04       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.